Medication info
Atorcen 20 mg (Atorvastatin Calcium Hydrate)

Atorcen 20 mg (Atorvastatin Calcium Hydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Hydrate›21.7mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
White round film-coated tablet
Packaging
For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle, For export - 30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 201505365 · Approved 2015.08.06 · Insurance code 698503090

Summary

Main use
Improvement of hyperlipidemia (including familial hyperlipidemia in children) and prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. The treatment goal is to lower LDL cholesterol; therefore, measurement of LDL cholesterol is recommended when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult population.
Children's dosage
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on administration of doses higher than 20 mg of this medicine in pediatric patients).

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hyperlipidemia in children) and prevention of cardiovascular disease

  • Myocardial infarction
  • stroke
  • vascular interventions
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps reduce the risk of various cardiovascular diseases and is used in the treatment of hyperlipidemia. It primarily reduces the risk of myocardial infarction, stroke, angina, and vascular interventions in adults with risk factors for heart disease and in patients with type 2 diabetes. It also lowers cholesterol and triglyceride levels in patients with hypercholesterolemia and mixed dyslipidemia, while raising levels of

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients who require a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. The treatment goal is to lower LDL cholesterol; therefore, measurement of LDL cholesterol is recommended when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medicine is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult population.

Children's dosage

Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on administration of doses higher than 20 mg of this medicine in pediatric patients).

Precautions

This medication may cause muscle-related symptoms; therefore, if there are severe muscle pain or weakness, or significant increases in creatine kinase levels, the medication should be stopped immediately, and a doctor should be consulted. Those with certain conditions, such as liver disease, pregnant women, children under 10 years old, and individuals with allergies to the medication should not take it. Those with a history of liver disease or alcohol abuse should carefully monitor liver function when using this medication, and dosage adjustments may be required as necessary. This medication can cause serious muscle disorders such as myopathy or rhabdomyolysis; if symptoms such as muscle pain, weakness, or fatigue occur, a doctor should be informed immediately and examinations should be conducted. Interactions may occur when taken with other medications, particularly those metabolized in the liver, certain antibiotics, antifungals, and antivirals; patients should inform their healthcare provider if they are taking these medicines. This medication should not be taken during pregnancy or breastfeeding, and women of childbearing age should use adequate contraceptive methods while taking it. Elderly patients or those with impaired kidney function may have a higher risk of side effects, so caution is needed during use, and regular checks of muscle condition and liver function should be conducted. In cases of overdose, there is no specific antidote, and treatment should be based on symptoms while monitoring liver function and muscle enzyme levels. Store this medication out of the reach of children and keep it in its original container to prevent misuse or degradation.

Side effects

  • Apathy
  • fatigue
  • chest pain
  • peripheral edema
  • tiredness
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 187 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • sore throat
  • hoarseness
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • rupture-related complications
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • nightmares
  • blurred vision
  • tinnitus
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • stomatitis
  • oral ulcer
  • glossitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • shortness of breath
  • asthma
  • epistaxis
  • sensory abnormalities
  • peripheral neuropathy
  • vertigo
  • photosensitivity reaction
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • motor coordination ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • tension increase
  • muscle cramps
  • muscle fatigue
  • myositis
  • muscle disorders
  • arthritis
  • bursitis
  • synovitis
  • myasthenia gravis
  • neck pain
  • tendon contraction
  • elevated CK
  • increased serum myoglobin
  • itching
  • rash
  • alopecia
  • contact dermatitis
  • skin dryness
  • sweating
  • acne
  • urticaria
  • eczema
  • seborrhea
  • skin ulcer
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency incontinence
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypoglycemia
  • hyperglycemia
  • loss of appetite
  • increased appetite
  • fatigue
  • vasomotor edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • ocular hemorrhage
  • hearing loss
  • glaucoma
  • altered taste
  • loss of taste
  • taste disorder
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. The suitable storage temperature is between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 100 tablets/bottle, For export - 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.